Profile data is unavailable for this security.
About the company
Healthlead Public Company Limited is a Thailand-based holding company. The principal businesses of the Company and its subsidiaries include pharmacy business distributing medicines, medical supplies, cosmeceuticals, supplements, medical devices, and other healthcare products as well as in business regarding invention business, developing, importing, and distributing healthcare products. It operates pharmacies under four brands namely Icare, Pharmax, vitaminclub, and Super Drug. The Company sells more than 10,000 stock-keeping units (SKUs) of medical supplies, cosmeceuticals, dietary supplements, medical equipment, and healthcare products via these pharmacies in response to customers’ various needs. Its pharmacies feature medicines, dietary supplements, medical equipment, household utensils, external healthcare products, and consumer goods. Its PRIME brand is a dietary supplement product, which includes PRIME Hibiki Collagen Pure and PRIME Acerola Cherry Extract 1200 MG.
- Revenue in THB (TTM)1.80bn
- Net income in THB76.21m
- Incorporated2020
- Employees484.00
- LocationHealthlead PCLNo. 37 Soi Sirikasem 7Bang Phai Subdistrict,, Bang KhaeNONTHABURI CITY 11140ThailandTHA
- Phone+66 21180884
- Websitehttps://www.healthleadgroup.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sophia Holdings Co Ltd | 1.97bn | -2.13m | 1.12bn | 193.00 | -- | 1.49 | 13.06 | 0.57 | -6.53 | -6.53 | 2,548.55 | 725.47 | 1.21 | 10.48 | 7.54 | 46,003,140.00 | -0.1307 | 2.93 | -0.2103 | 5.09 | 37.68 | 35.07 | -0.1082 | 2.32 | 1.57 | 11.17 | 0.4046 | 0.00 | -4.14 | 14.77 | -577.93 | -- | -12.58 | -- |
| Hyuga Primary Care Co Ltd | 1.93bn | 110.55m | 1.87bn | 544.00 | 17.31 | 4.76 | 11.76 | 0.9671 | 67.29 | 67.29 | 1,176.42 | 244.81 | 1.79 | 29.43 | 6.41 | 16,050,780.00 | 10.25 | -- | 16.41 | -- | 22.98 | -- | 5.72 | -- | 1.07 | 59.52 | 0.6145 | -- | 24.46 | -- | 15.19 | -- | -- | -- |
| Healthlead PCL | 1.80bn | 76.21m | 2.19bn | 484.00 | 28.73 | 2.29 | 15.45 | 1.22 | 0.2802 | 0.2802 | 6.62 | 3.52 | 1.33 | 5.22 | 147.76 | -- | 5.64 | 9.00 | 6.60 | 11.24 | 23.13 | 22.77 | 4.23 | 5.46 | 2.45 | 22.96 | 0.2145 | -- | 7.64 | -- | -36.84 | -- | -- | -- |
| Satudora Holdings Co Ltd | 21.39bn | 106.48m | 2.47bn | 1.11k | 22.53 | 1.19 | 6.10 | 0.1155 | 34.80 | 34.80 | 6,987.78 | 656.46 | 2.15 | 6.81 | 33.48 | 87,282,740.00 | 1.10 | 0.797 | 2.20 | 1.49 | 24.84 | 24.39 | 0.5133 | 0.3631 | 0.4631 | 12.17 | 0.6287 | 42.25 | 9.19 | 2.45 | 440.23 | 74.56 | -5.88 | 1.39 |
| Medical System Network Co Ltd | 25.93bn | 416.85m | 2.77bn | 3.74k | 6.53 | 0.7877 | 2.45 | 0.107 | 62.66 | 62.66 | 3,926.12 | 519.25 | 1.73 | 11.08 | 35.12 | 31,283,120.00 | 2.80 | 2.19 | 4.30 | 3.35 | 41.64 | 40.83 | 1.62 | 1.33 | 0.5703 | 15.09 | 0.6064 | 23.75 | 5.30 | 3.27 | 15.53 | 32.12 | -7.85 | 3.71 |
| Dingdang Health Technology Group Ltd | 23.06bn | -934.73m | 3.36bn | 2.51k | -- | 0.3654 | -- | 0.1457 | -0.1627 | -0.1627 | 4.02 | 1.59 | 1.57 | 5.61 | 43.27 | 2,041,874.00 | -6.53 | -55.91 | -9.42 | -82.51 | 32.38 | 32.74 | -4.17 | -35.83 | 1.86 | -- | 0.0766 | -- | 12.19 | 52.72 | 92.03 | -- | 13.40 | -- |
| Sunshine Holdings PLC | 6.46bn | 514.53m | 3.83bn | 1.70k | 7.45 | 1.80 | 4.88 | 0.5931 | 9.13 | 9.13 | 114.65 | 37.82 | 1.33 | 3.45 | 5.04 | 33,119,650.00 | 14.05 | 12.87 | 27.34 | 23.74 | 30.87 | 29.69 | 10.58 | 10.29 | 1.01 | 20.22 | 0.274 | 16.93 | 7.03 | 19.65 | 97.49 | 47.20 | -5.69 | 48.41 |
| Charmacy Pharmaceutical Co Ltd | 21.19bn | 244.59m | 4.20bn | 834.00 | 17.16 | 1.50 | 10.94 | 0.1981 | 0.5245 | 0.5245 | 45.43 | 6.00 | 1.47 | 5.49 | 4.76 | 5,904,141.00 | 1.70 | 1.79 | 8.48 | 7.99 | 6.91 | 6.16 | 1.15 | 1.24 | 0.7714 | 2.44 | 0.5882 | 37.09 | 5.47 | 2.27 | -43.25 | 2.48 | -16.01 | 0.0027 |
| Kimia Farma Tbk PT | 21.57bn | -3.65bn | 7.60bn | 10.71k | -- | 0.6683 | -- | 0.3523 | -307.59 | -311.08 | 1,817.52 | 957.72 | 0.5415 | 2.78 | 4.36 | 882,472,800.00 | -11.90 | -1.82 | -23.42 | -3.22 | 24.05 | 35.14 | -21.98 | -3.08 | 0.4154 | -3.76 | 0.5702 | -- | 7.93 | 3.33 | -737.71 | -- | -9.87 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Lion Global Investors Ltd.as of 30 Jun 2024 | 324.60k | 0.12% |
